Omalizumab for Chronic Urticaria: Aftermarket Reports of Efficacy and Side Effects
Crossref DOI link: https://doi.org/10.1007/s13671-017-0182-9
Published Online: 2017-04-22
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ghazanfar, Misbah Noshela
Thomsen, Simon Francis
License valid from 2017-04-22